ABSTRACT
A significant improvement in agonist activity of the previously described 2-aryloctahydrophenanthrene-2,3,7-triol series of dissociated glucocorticoid receptor agonists (DAGRs) was achieved by modifying the substitution at C3 from (S)-3-hydroxy to (R)-3-hydroxy-3-methyl. The IC50 of the prototype 13 in the efficacy assay measuring repression of IL-1 induced MMP-13 expression was 3.5 nM, exhibiting 87% of the maximal effect of dexamethasone (DEX). It displayed a dissociated profile by exhibiting 42% of the maximal effect of DEX in a mouse mammary tumor virus (MMTV) luciferase reporter transactivation assay. Compound 13 and analogues containing heterocyclic replacements for the C2 phenyl and modified B rings showed high repression of TNFα production in human whole blood, with IC50 values (43-167 nM) approaching the level of DEX (21 nM). On the basis of X-ray structures and force field calculations, the overall potency of this series was attributed to a favorable conformation of the C2α phenyl, induced by the neighboring C3α methyl.
Subject(s)
Phenanthrenes/chemistry , Phenanthrenes/pharmacology , Receptors, Glucocorticoid/agonists , Animals , Anti-Inflammatory Agents/pharmacology , Cell Line , Crystallography, X-Ray , Dexamethasone/pharmacology , Humans , Interleukin-1/immunology , Mammary Tumor Virus, Mouse/genetics , Matrix Metalloproteinase 13/genetics , Mice , Models, Molecular , Receptors, Glucocorticoid/metabolism , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/immunology , Up-Regulation/drug effectsABSTRACT
SAR studies and optimization of various modified Hygromycin A fluoroalkyl ethers, which led to the discovery of the highly potent 4'-(2-cyclopropyl-2-fluoroethyl ether) antibacterial CE-156811 (1) derived from truncation of the ribose ring and difluorination of the phenyl found in Hygromycin A, are discussed.
Subject(s)
Anti-Bacterial Agents/chemistry , Cinnamates/chemistry , Dioxoles/chemistry , Hygromycin B/analogs & derivatives , Administration, Oral , Animals , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacokinetics , Dogs , Drug Evaluation, Preclinical , Haplorhini , Hygromycin B/chemistry , Mice , Microbial Sensitivity Tests , Rats , Structure-Activity RelationshipABSTRACT
As exemplified by the lead compound 2, octahydrophenanthrene-2,7-diol analogues exhibit the profile of a pathway-selective or "dissociated" agonist of the glucocorticoid receptor (GR), retaining the potent activity that glucocorticoids have for transrepression (as measured by inhibition of IL-1 induced MMP-13 expression) but showing an attenuated capacity for transactivation (as measured in an MMTV luciferase reporter assay). With the guidance of a homology model of the GR ligand binding domain, structural modifications to 2 were carried out that were successful in replacing the allyl and propynyl side chains with groups likely to be more chemically stable and less likely to produce toxic metabolites. Key to success was the introduction of an additional hydroxyl group onto the tricyclic carbon framework of the series.
Subject(s)
Drug Discovery , Phenanthrenes/pharmacology , Receptors, Glucocorticoid/agonists , Chromatography, High Pressure Liquid , Crystallography, X-Ray , Mass Spectrometry , Models, Molecular , Phenanthrenes/chemistryABSTRACT
Succinyl hydroxamates 1 and 2 are disclosed as novel series of potent and selective inhibitors of procollagen C-proteinase (PCP) which may have potential as anti-fibrotic agents. Carboxamide 7 demonstrated good PCP inhibition and had excellent selectivity over MMPs involved in wound healing. In addition, 7 was effective in a cell-based model of collagen deposition (fibroplasia model) and was very effective at penetrating human skin in vitro. Compound 7 (UK-383,367) was selected as a candidate for evaluation in clinical studies as a topically applied, dermal anti-scarring agent.
Subject(s)
Bone Morphogenetic Protein 1/chemistry , Chemistry, Pharmaceutical/methods , Cicatrix, Hypertrophic/drug therapy , Cicatrix/drug therapy , Hydroxamic Acids/chemistry , Administration, Cutaneous , Cell Line, Tumor , Drug Design , Epidermis/drug effects , Fibrosis/pathology , Humans , Inhibitory Concentration 50 , Models, Chemical , Molecular Conformation , Oxazoles/chemistryABSTRACT
The identification of small molecule modulators of biological processes mediated via protein-protein interactions has generally proved to be a challenging endeavor. In the case of the thrombopoietin receptor (TPOr), however, a number of small molecule types have been reported to display biological activity similar to that of the agonist protein TPO. Through a detailed analysis of structure-activity relationships, X-ray crystal structures, NMR coupling constants, nuclear Overhauser effects, and computational data, we have determined the agonism-inducing conformation of one series of small molecule TPOr agonists. The relationship of this agonism-inducing conformation to that of other series of TPO receptor agonists is discussed.
Subject(s)
Benzamides/pharmacology , Pyrimidines/pharmacology , Receptors, Thrombopoietin/agonists , Thrombopoietin , Animals , Benzamides/chemistry , Cell Line , Computer Simulation , Crystallography, X-Ray , Magnetic Resonance Spectroscopy , Protein Binding , Protein Conformation , Pyrimidines/chemistry , Receptors, Thrombopoietin/chemistry , Structure-Activity Relationship , Thrombopoietin/chemistry , Thrombopoietin/metabolismABSTRACT
(-)-6-[2-[4-(3-Fluorophenyl)-4-hydroxy-piperidin-1-yl]-1-hydroxyethyl]-3,4-dihydro-quinolin-2(1H)-one (compound A) is an NR2B selective N-methyl d-aspartate (NMDA) antagonist that has shown at least two polymorphs, forms I and II. In this report, we prepared two polymorphs, forms I and II and their crystal forms were identified and characterized by single crystal X-ray diffractometry, differential scanning calorimetry (DSC) and variable temperature powder X-ray diffractometry (VT-PXRD). The results of DSC and VT-PXRD suggested that compound A has at least three polymorphic forms: I, II and a new form III, and that forms II and III showed an enantiotropic relationship. We also performed single crystal X-ray analyses of specific conditions based on the results of VT-PXRD. The unit cell dimensions in crystallographic parameter and molecular arrangements of form I were quite different from forms II and III. Whereas, the crystal structures of forms II and III were similar with the exception of the C58-C59-C61-C62 torsion angle.
Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Piperidines/pharmacology , Quinolones/pharmacology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Isomerism , Microscopy, Electron, Scanning , Models, Molecular , Molecular Conformation , Piperidines/chemistry , Quinolones/chemistry , X-Ray DiffractionABSTRACT
A cancer candidate, compound 1, is a weak base with two heterocyclic basic nitrogens and five hydrogen-bonding functional groups, and is sparingly soluble in water rendering it unsuitable for pharmaceutical development. The crystalline acid-base pairs of 1, collectively termed solid acid-base complexes, provide significant increases in the solubility and bioavailability compared to the free base, 1. Three dicarboxylic acid-base complexes, sesquisuccinate 2, dimalonate 3, and dimaleate 4, show the most favorable physicochemical profiles and are studied in greater detail. The structural analyses of the three complexes using crystal structure and solid-state NMR reveal that the proton-transfer behavior in these organic acid-base complexes vary successively correlating with Delta pKa. As a result, 2 is a neutral complex, 3 is a mixed ionic and zwitterionic complex and 4 is an ionic salt. The addition of the acidic components leads to maximized hydrogen bond interactions forming extended three-dimensional networks. Although structurally similar, the packing arrangements of the three complexes are considerably different due to the presence of multiple functional groups and the flexible backbone of 1. The findings in this study provide insight into the structural characteristics of complexes involving heterocyclic bases and carboxylic acids, and demonstrate that X-ray crystallography and 15N solid-state NMR are truly complementary in elucidating hydrogen bonding interactions and the degree of proton transfer of these complexes.
Subject(s)
Amines/chemistry , Dicarboxylic Acids/chemistry , Heterocyclic Compounds/chemistry , Crystallography, X-Ray , Drug Design , Hydrogen Bonding , Hydrogen-Ion Concentration , Macromolecular Substances/chemistry , Magnetic Resonance Spectroscopy , Molecular Structure , Nitrogen Isotopes , Receptor, ErbB-2/antagonists & inhibitors , SolubilityABSTRACT
1,5-Cyclooctadiene can be stereoselectively transformed into a substituted bicyclo[3.3.0]octane ring system under palladium catalysis with concomitant formation of three carbon-carbon bonds. Reaction with an aryl iodide or triflate and malonate gives an exo-endo product, while the reaction with a malonate in the presence of oxygen affords a bis-endo adduct.
ABSTRACT
A synthesis of 4,5-benzo-1-aza-tricyclo[4.3.1.1(3,8)]undecane (1), a benzo-1-aza-adamantane derivative, is described and features a previously unknown application of the Wolff-Kishner reduction of a nonresonance stabilized or "twisted" amide. An intermediate amino ester is converted to a severely "twisted amide", which, when exposed to hydrazine in alcohol, provides the corresponding "twisted" amino hydrazone. Wolff-Kishner conditions (KOH/ethylene glycol, 200 degrees C) provide the reduced target 1 without hydrolysis to amino acid derivatives. These operations are conveniently performed in a single flask in high yield.
Subject(s)
Adamantane/analogs & derivatives , Amides/chemistry , Aza Compounds/chemical synthesis , Adamantane/chemical synthesis , Adamantane/chemistry , Aza Compounds/chemistry , Crystallography, X-Ray , Molecular Structure , Oxidation-ReductionABSTRACT
An approach to the computer-assisted, pharmacophore design of nonsteroidal templates for the glucocorticoid receptor (GR) that contained an element of pseudo-C2 symmetry was developed. The enatiomer of the initial design, 1Ra, and not the designed molecule, 1S, showed the desired ligand binding to the GR. The pseudo-C2 symmetry of the template allowed for rapid improvements in GR activity resulting in potent, selective, nonsteroidal GR antagonists, CP-394531 and CP-409069.
Subject(s)
Phenanthrenes/chemical synthesis , Receptors, Glucocorticoid/antagonists & inhibitors , Binding, Competitive , Cell Line , Humans , Ligands , Models, Molecular , Phenanthrenes/chemistry , Phenanthrenes/pharmacology , Radioligand Assay , Receptors, Glucocorticoid/agonists , Receptors, Glucocorticoid/metabolism , Stereoisomerism , Structure-Activity Relationship , TransfectionABSTRACT
CJ-15,696 and 7 novel furopyridine antibiotics were isolated from the fungus Cladobotryum varium CL12284. Their structures were determined by X-ray crystallography and spectral analysis. Three biotransformed analogs were also prepared from CJ-15,696. CJ-15,696 showed moderate activity against various Gram-positive bacteria including some drug resistant strains such as methicillin resistant Staphylococcus aureus (MRSA).